Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1984 May 1;159(5):1388–1396. doi: 10.1084/jem.159.5.1388

Pathogenetic difference between collagen arthritis and adjuvant arthritis

PMCID: PMC2187290  PMID: 6201583

Abstract

Daily treatment with cyclosporin at a dose of 25 mg/kg for 14 d gave complete suppression of the development of collagen arthritis and adjuvant arthritis in Sprague-Dawley rats during an observation period of 45 d. To study whether the immunologic unresponsiveness produced by cyclosporin is antigen specific, we rechallenged the cyclosporin- protected rats with either type II collagen or complete Freund's adjuvant (CFA) after discontinuation of cyclosporin treatment. Type II collagen-immunized, cyclosporin-protected rats did not develop arthritis in response to reimmunization with type II collagen, but, they did develop arthritis in response to a subsequent injection of CFA. Similarly, CFA-injected, cyclosporin-protected rats showed a suppressed arthritogenic reaction in response to reinjection of CFA, whereas their response to a subsequent immunization with type II collagen was unaffected. On the other hand, the rats that were treated with cyclosporin without any prior antigenic challenge could develop arthritis in response to a subsequent injection of CFA or type II collagen after cessation of cyclosporin treatment. These results indicate that specific immunologic unresponsiveness can be induced by cyclosporin in the two experimental models of polyarthritis, collagen arthritis and adjuvant arthritis, and that there is no cross-reactivity between type II collagen and the mycobacterial cell wall components. The results further indicate that immunity to type II collagen plays a critical role in the pathogenesis of collagen arthritis but that its pathogenetic role in adjuvant arthritis is insignificant.

Full Text

The Full Text of this article is available as a PDF (587.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Borel J. F. Cyclosporin-A--present experimental status. Transplant Proc. 1981 Mar;13(1 Pt 1):344–348. [PubMed] [Google Scholar]
  2. Borel J. F., Feurer C., Gubler H. U., Stähelin H. Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions. 1976 Jul;6(4):468–475. doi: 10.1007/BF01973261. [DOI] [PubMed] [Google Scholar]
  3. Cremer M. A., Stuart J. M., Townes A. S., Kang A. H. Collagen-induced polyarthritis in rats: a study of native type II collagen for adjuvant activity. J Immunol. 1980 Jun;124(6):2912–2918. [PubMed] [Google Scholar]
  4. Green C. J., Allison A. C. Extensive prolongation of rabbit kidney allograft survival after short-term cyclosporin-A treatment. Lancet. 1978 Jun 3;1(8075):1182–1183. doi: 10.1016/s0140-6736(78)90970-4. [DOI] [PubMed] [Google Scholar]
  5. Green C. J., Allison A. C., Precious S. Induction of specific tolerance in rabbits by kidney allografting and short periods of cyclosporin-A treatment. Lancet. 1979 Jul 21;2(8134):123–125. doi: 10.1016/s0140-6736(79)90005-9. [DOI] [PubMed] [Google Scholar]
  6. Griffiths M. M., Eichwald E. J., Martin J. H., Smith C. B., DeWitt C. W. Immunogenetic control of experimental type II collagen-induced arthritis. I. Susceptibility and resistance among inbred strains of rats. Arthritis Rheum. 1981 Jun;24(6):781–789. doi: 10.1002/art.1780240605. [DOI] [PubMed] [Google Scholar]
  7. Hess A. D., Tutschka P. J., Santos G. W. Effect of cyclosporin A on human lymphocyte responses in vitro. II. Induction of specific alloantigen unresponsiveness mediated by a nylon wool adherent suppressor cell. J Immunol. 1981 Mar;126(3):961–968. [PubMed] [Google Scholar]
  8. Hess A. D., Tutschka P. J., Santos G. W. Effect of cyclosporin-A on human lymphocyte responses in vitro--induction of tolerance to alloantigens. Transplant Proc. 1981 Mar;13(1 Pt 1):374–378. [PubMed] [Google Scholar]
  9. Homan W. P., Fabre J. W., Williams K. A., Millard P. R., Morris P. J. Studies on the immunosuppressive properties of cyclosporin a in rats receiving renal allografts. Transplantation. 1980 May;29(5):361–366. doi: 10.1097/00007890-198005000-00003. [DOI] [PubMed] [Google Scholar]
  10. Iizuka Y., Chang Y. H. Adjuvant polyarthritis. VII. The role of type II collagen in pathogenesis. Arthritis Rheum. 1982 Nov;25(11):1325–1332. doi: 10.1002/art.1780251108. [DOI] [PubMed] [Google Scholar]
  11. Kaibara N., Hotokebuchi T., Takagishi K., Katsuki I. Paradoxical effects of cyclosporin A on collagen arthritis in rats. J Exp Med. 1983 Dec 1;158(6):2007–2015. doi: 10.1084/jem.158.6.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. McGregor A. M., Rennie D. P., Weetman A. P., Hassman R. A., Foord S. M., Dieguez C., Hall R. The influence of cyclosporin a on experimental autoimmune thyroid disease in the rat. Life Sci. 1983 Jan 3;32(1-2):97–108. doi: 10.1016/0024-3205(83)90177-7. [DOI] [PubMed] [Google Scholar]
  13. Morgan K., Clague R. B., Shaw M. J., Holt P. J. Native type II collagen-induced arthritis in the rat. I. Incidence and humoral response to collagen. Ann Rheum Dis. 1980 Jun;39(3):285–290. doi: 10.1136/ard.39.3.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Nussenblatt R. B., Rodrigues M. M., Salinas-Carmona M. C., Gery I., Cevario S., Wacker W. Modulation of experimental autoimmune uveitis with cyclosporin A. Arch Ophthalmol. 1982 Jul;100(7):1146–1149. doi: 10.1001/archopht.1982.01030040124022. [DOI] [PubMed] [Google Scholar]
  15. Stuart J. M., Cremer M. A., Kang A. H., Townes A. S. Collagen-induced arthritis in rats. Evaluation of early immunologic events. Arthritis Rheum. 1979 Dec;22(12):1344–1351. doi: 10.1002/art.1780221205. [DOI] [PubMed] [Google Scholar]
  16. Stuart J. M., Cremer M. A., Townes A. S., Kang A. H. Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis. J Exp Med. 1982 Jan 1;155(1):1–16. doi: 10.1084/jem.155.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Trentham D. E., Dynesius-Trentham R. A. Attenuation of an adjuvant arthritis by type II collagen. J Immunol. 1983 Jun;130(6):2689–2692. [PubMed] [Google Scholar]
  18. Trentham D. E., Dynesius R. A., David J. R. Passive transfer by cells of type II collagen-induced arthritis in rats. J Clin Invest. 1978 Aug;62(2):359–366. doi: 10.1172/JCI109136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Trentham D. E., McCune W. J., Susman P., David J. R. Autoimmunity to collagen in adjuvant arthritis of rats. J Clin Invest. 1980 Nov;66(5):1109–1117. doi: 10.1172/JCI109940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Trentham D. E., Townes A. S., Kang A. H. Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med. 1977 Sep 1;146(3):857–868. doi: 10.1084/jem.146.3.857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Trentham D. E., Townes A. S., Kang A. H., David J. R. Humoral and cellular sensitivity to collagen in type II collagen-induced arthritis in rats. J Clin Invest. 1978 Jan;61(1):89–96. doi: 10.1172/JCI108929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Tutschka P. J., Beschorner W. E., Allison A. C., Burns W. H., Santos G. W. Use of cyclosporin A in allogeneic bone marrow transplantation in the rat. Nature. 1979 Jul 12;280(5718):148–151. doi: 10.1038/280148a0. [DOI] [PubMed] [Google Scholar]
  23. Tutschka P. J., Beschorner W. E., Hess A. D. Use of cyclosporin A (CsA) in a rat model of allogeneic marrow transplantation. Haematol Blood Transfus. 1980;25:241–253. doi: 10.1007/978-3-642-67319-1_20. [DOI] [PubMed] [Google Scholar]
  24. Vladutiu A. O. Effect of cyclosporine on experimental autoimmune thyroiditis in mice. Transplantation. 1983 May;35(5):518–520. [PubMed] [Google Scholar]
  25. Voller A., Bidwell D. E., Bartlett A. Enzyme immunoassays in diagnostic medicine. Theory and practice. Bull World Health Organ. 1976;53(1):55–65. [PMC free article] [PubMed] [Google Scholar]
  26. Wang B. S., Heacock E. H., Chang-Xue Z., Tilney N. L., Strom T. B., Mannick J. A. Evidence for the presence of suppressor T lymphocytes in animals treated with cyclosporin A. J Immunol. 1982 Mar;128(3):1382–1385. [PubMed] [Google Scholar]
  27. Welles W. L., Battisto J. R. Suppression of adjuvant arthritis by antibodies specific for collagen type II. Immunol Commun. 1981;10(8):673–685. doi: 10.3109/08820138109051954. [DOI] [PubMed] [Google Scholar]
  28. Wick G., Müller P. U., Schwarz S. Effect of cyclosporin A on spontaneous autoimmune thyroiditis of Obese strain (OS) chickens. Eur J Immunol. 1982 Oct;12(10):877–881. doi: 10.1002/eji.1830121014. [DOI] [PubMed] [Google Scholar]
  29. Wood F. D., Pearson C. M., Tanaka A. Capacity of mycobacterial wax D and its subfractions to induce adjuvant arthritis in rats. Int Arch Allergy Appl Immunol. 1969;35(5):456–467. doi: 10.1159/000230198. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES